125 related articles for article (PubMed ID: 20450431)
1. Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease.
Sancak S; Hardt A; Singer J; Klöppel G; Eren FT; Güllüoglu BM; Sen LS; Sever Z; Akalin NS; Eszlinger M; Paschke R
Thyroid; 2010 May; 20(5):505-11. PubMed ID: 20450431
[TBL] [Abstract][Full Text] [Related]
2. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?
Anderson SR; Mandel S; LiVolsi VA; Gupta PK; Baloch ZW
Diagn Cytopathol; 2004 Jul; 31(1):64-7. PubMed ID: 15236269
[TBL] [Abstract][Full Text] [Related]
3. Increased percentage of microvessels but decreased density of large vessels in papillary carcinomas as compared to hot and cold thyroid nodules.
Sancak S; Hardt A; Ricken A; Lorenz S; Eszlinger M; Sen LS; Güllüoglu BM; Sever Z; Eren FT; Akalin NS; Paschke R
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):637-44. PubMed ID: 19609842
[TBL] [Abstract][Full Text] [Related]
4. Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinoma.
Pohl M; Grabellus F; Worm K; Arnold G; Walz M; Schmid KW; Sheu-Grabellus SY
J Clin Pathol; 2017 Jan; 70(1):33-39. PubMed ID: 27371612
[TBL] [Abstract][Full Text] [Related]
5. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
[TBL] [Abstract][Full Text] [Related]
6. CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma.
Khan A; Baker SP; Patwardhan NA; Pullman JM
Virchows Arch; 1998 May; 432(5):427-32. PubMed ID: 9645441
[TBL] [Abstract][Full Text] [Related]
7. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease.
Erkiliç S; Koçer NE
Endocr Pathol; 2005; 16(1):63-6. PubMed ID: 16000848
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 free from extracellular matrix is increased in papillary thyroid carcinomas and Graves' thyroids.
Emoto N; Onose H; Sugihara H; Minami S; Shimizu K; Wakabayashi I
Thyroid; 1998 Jun; 8(6):491-7. PubMed ID: 9669286
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
[TBL] [Abstract][Full Text] [Related]
11. Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues.
Geers C; Colin IM; Gérard AC
Thyroid; 2011 Dec; 21(12):1323-30. PubMed ID: 22066479
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of peroxisome proliferator-activated receptor-gamma expression in benign and malignant thyroid pathologies.
Karger S; Berger K; Eszlinger M; Tannapfel A; Dralle H; Paschke R; Führer D
Thyroid; 2005 Sep; 15(9):997-1003. PubMed ID: 16187907
[TBL] [Abstract][Full Text] [Related]
13. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of the gap junction protein connexin43 is associated with papillary thyroid carcinomas when compared with other noncancer pathologies of the thyroid.
Dominguez C; Karayan-Tapon L; Desurmont T; Gibelin H; Crespin S; Fromont G; Levillain P; Bouche G; Cantereau A; Mesnil M; Kraimps JL
Thyroid; 2011 Oct; 21(10):1057-66. PubMed ID: 21875346
[TBL] [Abstract][Full Text] [Related]
15. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtype expression in human thyroid tumours.
Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
[TBL] [Abstract][Full Text] [Related]
17. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas.
Trovato M; Grosso M; Vitarelli E; Ruggeri RM; Alesci S; Trimarchi F; Barresi G; Benvenga S
Histol Histopathol; 2003 Apr; 18(2):393-9. PubMed ID: 12647789
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor expression in thyroid disease.
Atkinson H; England JA; Rafferty A; Jesudason V; Bedford K; Karsai L; Atkin SL
Int J Exp Pathol; 2013 Jun; 94(3):226-9. PubMed ID: 23672766
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours.
Fuhrer D; Eszlinger M; Karger S; Krause K; Engelhardt C; Hasenclever D; Dralle H; Paschke R
Eur J Endocrinol; 2005 May; 152(5):785-90. PubMed ID: 15879365
[TBL] [Abstract][Full Text] [Related]
20. Thyroid nodules and thyroid cancer in Graves' disease.
Tam AA; Kaya C; Kılıç FB; Ersoy R; Çakır B
Arq Bras Endocrinol Metabol; 2014 Dec; 58(9):933-8. PubMed ID: 25627049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
